287
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Spatial analyses of ALS incidence in Denmark over three decades

, , &
Pages 275-284 | Received 18 Jun 2017, Accepted 21 Jan 2018, Published online: 31 Jan 2018

References

  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10:769–82.
  • Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
  • Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852:679–84.
  • Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chio A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 S1:33–43.
  • Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, et al. ALS and PDC of Guam: forty-year follow-up. Neurology. 2002;58:765–73.
  • Zhang ZX, Anderson DW, Mantel N, Roman GC. Motor neuron disease on Guam: temporal occurrence, 1941–85. Acta Neurol Scand. 1995;92:299–307.
  • Kuzuhara S, Kokubo Y. Atypical Parkinsonism of Japan: amyotrophic lateral sclerosis-Parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update. Mov Disord. 2005;20 S12:S108–S13.
  • Yase Y. The pathogenesis of amyotrophic lateral sclerosis. Lancet. 1972;2:292–6.
  • Foster HD. Amyotrophic lateral sclerosis: two for the price of one? In: Foster HD, ed. Health, disease and the environment. London, United Kingdom: Belhaven Press, 1992:439–78.
  • Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992;55:1106–15.
  • Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G. Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry. 1998;65:842–7.
  • Mitchell JD, Gibson HN, Gatrell A. Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976–1986. A geographical study. Arch Neurol. 1990;47:875–80.
  • Gunnarsson LG, Lygner PE, Veiga-Cabo J, de Pedro-Cuesta J. An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973–1984. Neuroepidemiology. 1996;15:142–52.
  • Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol. 1989;42:569–75.
  • Betemps EJ, Buncher CR. Birthplace as a risk factor in motor neuron disease and Parkinson's disease. Int J Epidemiol. 1993;22:898–904.
  • Sabel CE, Boyle PJ, Loytonen M, Gatrell AC, Jokelainen M, Flowerdew R, et al. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol. 2003;157:898–905.
  • Jokelainen M, Palo J, Wikstrom J. The distribution of amyotrophic lateral sclerosis in Finland. J Neurol Sci. 1975;25:473–9.
  • Jokelainen M, Wikstrom J, Palo J. Effect of birthplace on the development of amyotrophic lateral sclerosis and multiple sclerosis. A study among Finnish war evacuees. Act Neurol Scandinav. 1979;60:283–8.
  • Sabel CE, Gatrell AC, Loytonen M, Maasilta P, Jokelainen M. Modelling exposure opportunities: estimating relative risk for motor neuron disease in Finland. Soc Sci Med. 2000;50:1121–37.
  • Caller TA, Doolin JW, Haney JF, Murby AJ, West KG, Farrar HE, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler. 2009;10 S2:101–8.
  • Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13:25–32.
  • Migliaretti G, Berchialla P, Dalmasso P, Cavallo F, Chio A. Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:58–65.
  • Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, Ampong MA, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009;32:81–8.
  • Alonso V, Villaverde-Hueso A, Hens MJ, Morales-Piga A, Abaitua I, de la Paz MP. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990–2005). Amyotroph Lateral Scler. 2011;12:192–8.
  • Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007;22:781–90.
  • Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.
  • Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004. J Neurol Sci. 2010;298:78–84.
  • Rooney J, Heverin M, Vajda A, Crampsie A, Tobin K, Byrne S, et al. An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995–July 2013). PLoS One. 2014;9:e96556.
  • Rooney J, Vajda A, Heverin M, Elamin M, Crampsie A, McLaughlin R, et al. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 2015;84:1537–44.
  • Chio A, Mora G, Moglia C, Manera U, Canosa A, Cammarosano S, et al. Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d'Aosta Register. JAMA Neurol. 2017;74:1097–104.
  • Seals R, Gredal O, Hansen J, Weisskopf MG. Physical trauma and risk of ALS: a population-based study. San Diego, CA, USA: American Academy of Neurology; 2013.
  • Seals R, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970–2009. Am J Epidemiol. 2013;178:1265–71.
  • Kioumourtzoglou MA, Seals R, Himmerslev L, Gredal O, Hansen J, Weisskopf MG. Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:224–9.
  • Webster T, Vieira V, Weinberg J, Aschengrau A. Method for mapping population-based case-control studies: an application using generalized additive models. Int J Health Geogr. 2006;5:26.
  • Hastie T, Tibshirani R. Generalized additive models. London: Chapman and Hall, Publishers; 1990.
  • Kelsall J, Diggle P. Spatial variation in risk of disease: a nonparametric binary regression approach. J R Stat Soc Ser C Appl Stat. 1998;47:559–73.
  • Wood S. Generalized additive models: an introduction with R. London: Chapman and Hall, Publishers; 2006.
  • Vieira V, Webster T, Weinberg J, Aschengrau A, Ozonoff D. Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data. Environ Health. 2005;4:11.
  • Vieira VM, Bartell SM, Bliss RY. MapGAM: mapping smoothed effect estimates from individual-level data. R package version 0.7-5. 2015. Accessed 11/23/2017. Available at: http://CRAN.R-project.org/package=MapGAM
  • Bai L. Adaptive statistical methods for the analysis of sequential and spatial observation data [dissertation]. Irvine, CA, USA: University of California, Irvine; 2016.
  • Bliss RY, Weinberg J, Vieira VM, Ozonoff A, Webster TF. Power of permutation tests using generalized additive models with bivariate smoothers. J Biomet Biostat. 2010;1:104.
  • Young RL, Weinberg J, Ozonoff A, Vieira V, Webster TF. Generalized additive models and inflated type I error rates of smoother significance tests. Comput Stat Data Anal. 2011;55:366–74.
  • Young RL, Weinberg J, Vieira V, Ozonoff A, Webster TF. A power comparison of generalized additive models and the spatial scan statistic in a case-control setting. Int J Health Geogr. 2010;9:37.
  • Bliss RL, Weinberg J, Vieira VM, Webster TF. Adjusted significance cut-offs for hypothesis tests applied with generalized additive models with bivariate smoothers. Spatial Spatio-temporal Epidemiol. 2011;2:291–300.
  • Bliss R, Weinberg J, Webster T, Vieira V. Determining the probability distribution and evaluating sensitivity and false positive rate of a confounder detection method applied to logistic regression. J Biomet Biostat. 2012;3:142.
  • Siangphoe U, Wheller DC. Evaluation of the performance of smoothing functions in generalized additive models for spatial variation in disease. Cancer Inform. 2015;14(S2):107–16.
  • Sin DD, Cohen SB, Day A, Coxson H, Pare PD. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc. 2007;4:671–4.
  • Alonso A, Logroscino G, Hernan MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81:1249–52.
  • Hansen J, Raaschou-Nielsen O, Olsen JH. Incresaed risk of lung cancer among different types of professional drivers in Denmark. Occup Environ Med. 1998;55:115–8.
  • Toch-Marquardt M, Menvielle G, Eikemo TA, Kulhánová I, Kulik MC, Bopp M, et al. Occupational class inequalities in all-cause and cause-specific mortality among middle-aged men in 14 European populations during the early 2000s. Plos One. 2014;9:e108072.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.